BOSTON, July 10, 2018 /PRNewswire-PRWeb/ --áConnance, a healthcare leader in predictive analytics to personalize the
"As the healthcare industry evolves to treat patients more holistically, it is becoming increasingly important to understand and consider non-medical factors such as food access, home stability and health literacy when developing a care plan," said Paul Isabelli, Caradigm Vice President and GM of Population Health. "Through the integration of social determinant data and analytics into Caradigm solutions, healthcare providers will be able to better assess and care for their patient populations."
Connance will connect its Value-Based Risk Analytics solution through Caradigm's suite of applications, providing their customers seamless access to patient-specific social determinant risk profiles and predictive analytics. This solution gathers and analyzes patient data to develop patient-specific risk profiles along multiple social determinant of health dimensions, including access to transportation, access to healthy food, health literacy and financial stress. Additionally, predictive analytics will help providers deploy their limited resources for maximum impact. Embedding this Whole Patient Insight« into Caradigm's population health solutions provides Caradigm customers an unparalleled understanding of their patient's health status to drive better outcomes and lower total cost of care.
"Despite multiple studies showing that socioeconomic and behavioral factors are responsible for upwards of 75 percent of an individual's health, most payers and providers rely solely on clinical or claims data for patient care. Social determinants of health have been more difficult to systematically collect and leverage for patient segmentation, risk stratification and care management," said Ryan Bengtson, senior vice president, Clinical Innovation, Connance. "Our Value-Based Risk Analytics solve this problem in an innovative manner by aggregating publicly and commercially available data in addition to relevant clinical information about the patient. By leveraging this additional data, we can better assess the true risk of the patient and enable more proactive and targeted care delivery."
To learn more about the Connance Value-Based Risk Analytics, please visit our website.
About Connance, Inc. Connance is the healthcare industry's leading provider of predictive analytics solutions that personalize the financial and clinical experience for patients. Transforming the revenue cycle and value-based care delivery, Connance leverages data science, integrated to workflow to drive enhanced performance. Connance delivers Patient Pay Optimization, Reimbursement Optimization and Value-Based Risk solutions that combine Connance data, hospital data and consumer data to stratify patients based on social determinants to predict behavior and provide actionable insights to improve net income and patient outcomes. Connance solutions connect more than 500 hospitals, thousands of physician practices and other clinical locations and more than 80 collection agencies nationwide creating the largest research database of its kind. For more information, call (781) 577-5000 or visit our website.
About Caradigm Caradigm is an Inspirata company offering intelligent healthcare analytics and population health management solutions. Caradigm is dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement. Caradigm's customers include large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers and community hospital networks. Based in Redmond, WA, Caradigm received the Frost & Sullivan 2017 North American Health IT Value-Based Care Management Product Leadership Award. For more information, visit our website.
SOURCE Connance, Inc.
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All